CAR-T-Zell-Therapie Logo
  • Aktuelles
  • Studien
  • Zentren
  • Patienteninfos
  • Fortbildung
  • Zulassungen
  • Fachbeiträge
  • Community
  • Login
Suche
zurück zur Zentren Übersicht
Niedersachsen

Medizinische Hochschule Hannover, Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation

Carl-Neuberg-Str. 1
D-30625 Hannover
Leitung: Prof. Dr. med. Florian Heidel

Studien

  • INTEGRATE ATMP
  • A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
  • Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies
  • Extracorporeal Cytokine Adsorption as Additive Treatment of CAR-T Associated Cytokine Release Syndrome (CRS) (CYTORELEASE)
  • A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
  • A Trial to Evaluate the Safety and Efficacy of CLDN6 CAR-T +/- CLDN6 RNA-LPX

Kontakt

Prof. Dr. Christian Könecke
koenecke.christian@mh-hannover.de
+49 511-532-83763
PD Dr. med. Christian Schultze-Florey
Schultze-Florey.Christian@mh-hannover.de
+49 511 532 2424
+49 511 532-3020

Studien

  • INTEGRATE ATMP
  • A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
  • Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies
  • Extracorporeal Cytokine Adsorption as Additive Treatment of CAR-T Associated Cytokine Release Syndrome (CRS) (CYTORELEASE)
  • A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
  • A Trial to Evaluate the Safety and Efficacy of CLDN6 CAR-T +/- CLDN6 RNA-LPX
  • Aktuelles
  • Studien
  • Zentren
  • Patienteninfos
  • Fortbildung
  • Fachbeiträge
  • Zulassungen
  • Community
  • CARTakut
  • Aktuelles
  • Studien
  • Zentren
  • Patienteninfos
  • Fortbildung
  • Fachbeiträge
  • Zulassungen
  • Community
  • CARTakut
Ein Projekt von:
In Zusammenarbeit mit:
  • Impressum
  • Datenschutz
  • Cookie Einstellungen